The 10 most recent market catalysts affecting $SXTC, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Oct 24, 2026
Corporate Catalyst
Neutral
Impact 65
China SXT Pharmaceuticals Announces 1-for-100 Reverse Stock Split
China SXT Pharmaceuticals announced a 1-for-100 reverse stock split, effective October 26, 2026. This corporate action significantly reduces the number of outstanding shares and pr…
Oct 13, 2026
Market Technicals
Bearish
Impact 60
Stock Market Today: Dow Jones Futures Gain, Nasdaq, S&P 500 Falls as Scott Bessent Says Iran's Economy Is 'Collapsing'— SXTC, AMAT, CMG in Focus (UPDATED)
The filing details a mixed market open with Dow futures up but S&P 500 and Nasdaq down, driven by negative small business sentiment and geopolitical concerns around Iran. This matt…
Oct 8, 2026
Corporate Catalyst
Bearish
Impact 85
China SXT Pharmaceuticals shares are trading lower after the company announced a $12 million offering of 8 million shares at $1.50 per share.
This headline signifies a significant corporate action for China SXT Pharmaceuticals (SXTC). The offering of 8 million shares at $1.50 per share, totaling $12 million, represents s…
Oct 8, 2026
Macro/Central Bank
Bearish
Impact 65
Dow Falls Over 100 Points; US Initial Jobless Claims Decline
The market experienced a broad decline across the Dow, NASDAQ, and S&P 500, indicating a general risk-off sentiment. This occurred despite initial jobless claims falling below mark…
Oct 8, 2026
Corporate Catalyst
Bullish
Impact 75
China SXT Pharmaceuticals Commences ~$12M Offering Of 8M Class A Ordinary Shares At $1.50 Per Share
China SXT Pharmaceuticals is conducting a registered direct offering to institutional investors, selling 8 million Class A ordinary shares at $1.50 each, expecting to raise $12 mil…
Oct 7, 2026
Market Technicals
Bullish
Impact 55
12 Health Care Stocks Moving In Wednesday's Intraday Session
This 8-K filing, generated by Benzinga's automated content engine, simply reports the intraday performance of 12 healthcare stocks. It does not disclose any specific corporate even…
Aug 5, 2026
Corporate Catalyst
Bearish
Impact 85
China SXT Pharmaceuticals shares are trading lower after the company announced a 1-for-80 reverse stock split.
A 1-for-80 reverse stock split is an extreme measure, indicating severe share price depreciation and likely a company struggling to meet minimum bid price requirements for exchange…
Aug 5, 2026
Corporate Catalyst
Neutral
Impact 75
China SXT Pharmaceuticals Announces 1-For-80 Reverse Stock Split, Effective Aug. 10
China SXT Pharmaceuticals is implementing a 1-for-80 reverse stock split, a corporate action where the number of outstanding shares is reduced, and the price per share is proportio…
Jul 23, 2026
Corporate Catalyst
Bearish
Impact 75
China SXT Pharmaceuticals shares are trading lower after the company announced a $9 million registered direct offering.
The announcement of a registered direct offering for China SXT Pharmaceuticals (SXTC) is a significant corporate catalyst. These offerings increase the number of outstanding shares…
Jul 23, 2026
Corporate Catalyst
Bullish
Impact 75
China SXT Pharmaceuticals Commences ~$9M Offering Of 4.5M Class Ordinary Shares At $3.20/Share
China SXT Pharmaceuticals (SXTC) announced a registered direct offering to raise approximately $9 million. The company will sell 4.5 million units, each comprising a Class A ordina…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.